Stockreport

Virpax® Pharmaceuticals Announces Pricing of $40 Million Public Offering of Common Stock

Virpax Pharmaceuticals, Inc.  (VRPX) 
PDF BERWYN, Pa.--(BUSINESS WIRE)--Virpax® Pharmaceuticals Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing pharmaceutical products fo [Read more]